Compare JAZZ & MLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAZZ | MLI |
|---|---|---|
| Founded | 2003 | 1917 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 11.9B |
| IPO Year | 2007 | N/A |
| Metric | JAZZ | MLI |
|---|---|---|
| Price | $162.98 | $114.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $207.19 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 916.2K |
| Earning Date | 02-24-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 0.87% |
| EPS Growth | N/A | ★ 29.19 |
| EPS | N/A | ★ 6.86 |
| Revenue | $4,157,832,999.00 | ★ $4,178,546,999.00 |
| Revenue This Year | $6.05 | $12.24 |
| Revenue Next Year | $6.23 | $8.09 |
| P/E Ratio | ★ N/A | $16.80 |
| Revenue Growth | 4.14 | ★ 10.87 |
| 52 Week Low | $95.49 | $66.84 |
| 52 Week High | $182.99 | $139.29 |
| Indicator | JAZZ | MLI |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 36.71 |
| Support Level | $162.24 | $112.58 |
| Resistance Level | $168.47 | $139.29 |
| Average True Range (ATR) | 4.02 | 3.55 |
| MACD | -0.39 | -2.84 |
| Stochastic Oscillator | 36.31 | 12.80 |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Mueller Industries Inc makes copper, brass, aluminum, and plastic products. The company reports three business segments: piping systems, industrial metals, and climate. Piping systems, earning majority of the company's revenue, produces tubes, fittings, rods, valves, and other products and operates various firms world-wide. The industrial metals segment manufactures impacts and micro-gauge, brass rod and copper bar products, and brass value-added products. The climate segment produces items used to create temperature-control goods, including valves, twisted tubes, coaxial heat exchangers, and others. Numerous systems use the aforementioned products, including HVAC, water distribution, refrigeration, and automotive.